← SynDRA
DESERPIDINE
SynDRA canonical compound SYN0023036 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | SLC18A2 |
|---|
| Mechanism of action | Angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC18A2 INHIBITOR
- Synaptic vesicular amine transporter inhibitor
- SLC33A1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNH2
- ESR1
- MC4R
- OPRM1
- ADORA1
- OPRD1
- HTR2C
- HTR3A
- KAT2A
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRK1
- HTR2A
- PDE3A
- PDE4D
- PGR
- POLK
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- TDP1
- USP1
- HTR2B
- HTR1A
- ADORA2A
- HRH2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Catecholamine-depleting Sympatholytic
ATC classes
- C02A · ANTIADRENERGIC AGENTS, CENTRALLY ACTING
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- ENDURONYL
- ENDURONYL FORTE
- HARMONYL
- METHYCLOTHIAZIDE AND DESERPIDINE
- ORETICYL 25
- ORETICYL 50
- ORETICYL FORTE
- deserpidin
- raunormin
- raunormine
- recanescin
- recanescine
- reserpidine
- Deserpidina
- Deserpidine, (-)-
- Halmonyl
- NSC-72138
- Deserpidine component of enduronyl
- Deserpidine component of oreticyl forte
- Harmonyl
- Canescin
- Canescine
- Deresperine
- Desepridine
- Deserpidin
- Deserpidinum
- Desmethoxyreserpine
- Raunormin
- Raunormine
- Recanescin
- Recanescine
- Reserpidine
- Tranquinil
- Lilly 22641
- A-11025
- Deserpidina [INN-Spanish]
- Deserpidine (INN)
- Deserpidine [INN:BAN]
Look up DESERPIDINE in the interactive SynDRA portal →